Royal Marsden Nhs Foundation Trust

This early-stage trial aimed to see if combining the immunotherapy drug pembrolizumab with precise radiation (SBRT) to a lung tumor is safe for people with advanced non-small-cell lung cancer that has spread. Only 2 patients were enrolled before the study was stopped. The main go…

This early-phase study tested adding the immune-boosting drug pembrolizumab to standard chemoradiation for people with locally advanced cervical cancer. The goal was to see if the combination was safe and could help the immune system fight cancer more effectively. Only one person…